|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.01 USD | -0.06% |
|
-0.82% | +35.00% |
| Market Cap | 5.43B 4.75B 4.38B 4.04B 7.67B 518B 7.8B 52.31B 20.54B 255B 20.38B 19.93B 877B | P/E 2026 * |
49.6x | P/E 2027 * | 21x |
|---|---|---|---|---|---|
| Enterprise Value | 7.71B 6.74B 6.22B 5.74B 10.9B 735B 11.08B 74.31B 29.18B 362B 28.94B 28.31B 1,245B | EV / Sales 2026 * |
2.48x | EV / Sales 2027 * | 2.17x |
| Free-Float |
47.1% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Amneal Pharmaceuticals, Inc.
| 1 day | -0.06% | ||
| 1 week | -0.82% | ||
| Current month | -1.73% | ||
| 1 month | +11.03% | ||
| 3 months | +35.65% | ||
| 6 months | +31.25% | ||
| Current year | +35.00% |
| 1 week | 16.45 |  | 17.42 |
| 1 month | 15.73 | | 17.86 |
| Current year | 11.71 | | 17.86 |
| 1 year | 7.66 | | 17.86 |
| 3 years | 2.95 | | 17.86 |
| 5 years | 1.24 | | 17.86 |
| 10 years | 1.24 | | 24.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 10 | Sell | Director | -34,819 | 0.0109% | ||
| May. 06 | Fiscal year | Director | 69,638 | 0.0218% | ||
| May. 06 | Fiscal year | Director | 69,638 | 0.0218% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | -0.82% | +102.74% | +465.12% | 5.43B | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.81% | -3.00% | +32.24% | +96.47% | 357.93B | |
| Weighted average by Cap. | -0.56% | -2.95% | +35.38% | +81.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.11B 2.72B 2.51B 2.31B 4.39B 296B 4.47B 29.94B 11.76B 146B 11.66B 11.41B 502B | 3.33B 2.91B 2.69B 2.48B 4.71B 318B 4.79B 32.1B 12.6B 156B 12.5B 12.23B 538B |
| Net income | 113M 98.57M 90.92M 83.97M 159M 10.75B 162M 1.09B 427M 5.29B 423M 414M 18.2B | 270M 236M 218M 201M 381M 25.71B 388M 2.6B 1.02B 12.67B 1.01B 990M 43.55B |
| Net Debt | 2.28B 2B 1.84B 1.7B 3.23B 218B 3.28B 22B 8.64B 107B 8.57B 8.38B 369B | 1.8B 1.57B 1.45B 1.34B 2.54B 172B 2.59B 17.34B 6.81B 84.49B 6.75B 6.61B 290B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | $17.01 | -0.06% | 1,733,358 |
| 26-07-09 | $17.02 | +0.35% | 1,553,761 |
| 26-07-08 | $16.96 | -0.53% | 1,752,329 |
| 26-07-07 | $17.05 | +0.77% | 1,815,990 |
| 26-07-06 | $16.92 | -1.34% | 1,685,695 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
